Bipolar disorders: A review

American Family Physician

Volumn 85, Issue 5, 2012, Pages 483-493

  Price, Amy L ^a   Marzani Nissen, Gabrielle R ^b  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; HALOPERIDOL; LAMOTRIGINE; LITHIUM; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

AGE; AGITATION; AKATHISIA; ANTEROGRADE AMNESIA; ANXIETY; ANXIETY DISORDER; ASEPTIC MENINGITIS; ATAXIA; BIPOLAR DISORDER; BIPOLAR I DISORDER; BLOOD DYSCRASIA; BODY WEIGHT; COGNITIVE DEFECT; DEPRESSION; DIABETES INSIPIDUS; DIARRHEA; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; EARLY DIAGNOSIS; ELECTROCONVULSIVE THERAPY; ENVIRONMENTAL FACTOR; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; HAIR LOSS; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERPROLACTINEMIA; HYPERTRANSAMINASEMIA; HYPOMANIA; HYPONATREMIA; HYPOTENSION; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; INSOMNIA; LEUKOPENIA; LIVER FAILURE; LOADING DRUG DOSE; MAINTENANCE THERAPY; MANIA; MENTAL HEALTH; MIXED MANIA AND DEPRESSION; MONOTHERAPY; MOOD CHANGE; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; NYSTAGMUS; ORTHOSTATIC HYPOTENSION; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PANCYTOPENIA; PATIENT MONITORING; PNEUMONIA; POLYURIA; PSYCHOSIS; PSYCHOTHERAPY; QT PROLONGATION; RASH; RELAPSE; RESPIRATION DEPRESSION; RESTLESSNESS; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SUBSTANCE ABUSE; SUICIDAL IDEATION; TARDIVE DYSKINESIA; THIRST; THROMBOCYTOPENIA; TOXIC EPIDERMAL NECROLYSIS; TREMOR; WEIGHT GAIN; XEROSTOMIA;

EID: 84857972302     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. Am J Psychiatry. 1995;152(11):1635-1640.
2. Judd LL, Akiskal HS, Schettler PJ, et al. Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study. Arch Gen Psychiatry. 2005;62(12):1322-1330.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision. Washington, DC: American Psychiatric Association; 2000.
4. World Health Organization. The global burden of disease: 2004 update. Part 3: disease incidence, prevalence and disability. http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/. Accessed May 19, 2011.
5. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication [published correction appears in Arch Gen Psychiatry. 2007;64(9):1039]. Arch Gen Psychiatry. 2007;64(5):543-552.
6. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 suppl):1-50.
7. Parikh SV, LeBlanc SR, Ovanessian MM. Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Can J Psychiatry. 2010;55(3):136-143.
8. Fiedorowicz JG, Solomon DA, Endicott J, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med. 2009;71(6):598-606.
9. Novick DM, Swartz HA, Frank E. Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord. 2010;12(1):1-9.
10. Cassidy F. Risk factors of attempted suicide in bipolar disorder. Suicide Life Threat Behav. 2011;41(1):6-11.
11. Barnett JH, Smoller JW. The genetics of bipolar disorder. Neuroscience. 2009;164(1):331-343.
12. Goldstein BI, Shamseddeen W, Axelson DA, et al. Clinical, demographic, and familial correlates of bipolar spectrum disorders among offspring of parents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2010;49(4):388-396.
13. Proudfoot J, Doran J, Manicavasagar V, Parker G. The precipitants of manic/hypomanic episodes in the context of bipolar disorder: a review. J Affect Disord. 2010. http://www.sciencedirect.com/science/article/pii/S0165032710006804 (subscription required). Accessed September 14, 2011.
14. Van Snellenberg JX, de Candia T. Meta-analytic evidence for familial coaggregation of schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2009;66(7):748-755.
15. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60(5):497-502.
16. Luykx JJ, Boks MP, Terwindt AP, Bakker S, Kahn RS, Ophoff RA. The involvement of GSK3beta in bipolar disorder: integrating evidence from multiple types of genetic studies. Eur Neuropsychopharmacol. 2010;20(6):357-368.
17. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002;59(6):530-537.
18. Manning JS. Tools to improve differential diagnosis of bipolar disorder in primary care. Primary Care Companion J Clin Psychiatry. 2010;12(suppl 1):17-22.
19. Goldberg JF, McElroy SL. Bipolar mixed episodes: characteristics and comorbidities. J Clin Psychiatry. 2007;68(10):e25.
20. U.S. Preventive Services Task Force. Screening and treatment for major depressive disorder in children and adolescents. March 2009. http://www.uspreventiveservicestaskforce.org/uspstf09/depression/chdeprrs.htm. Accessed September 14, 2011.
21. Zimmerman M, Galione JN, Chelminski I, Young D, Ruggero CJ. Performance of the Bipolar Spectrum Diagnostic Scale in psychiatric outpatients. Bipolar Disord. 2010;12(5):528-538.
22. Gaynes BN, DeVeaugh-Geiss J, Weir S, et al. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care. Ann Fam Med. 2010;8(2):160-169.
23. Zimmerman M, Galione JN, Ruggero CJ, et al. Performance of the mood disorders questionnaire in a psychiatric outpatient setting. Bipolar Disord. 2009;11(7):759-765.
24. Family Practice Notebook. Mania secondary causes. http://www.fpnotebook.com/Psych/Bipolar/MnScndryCs.htm. Accessed September 14, 2011.
25. Family Practice Notebook. Bipolar disorder. http://www.fpnotebook.com/Psych/Bipolar/BplrDsrdr.htm. Accessed September 14, 2011.
26. Berk M, Brnabic A, Dodd S, et al. Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord. 2011;13(1):87-98.
27. Yatham LN, Kennedy SH, Schaffer A, et al.; Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225-255.
28. Macritchie K, Geddes JR, Scott J, Haslam D, de Lima M, Goodwin G. Valproate for acute mood episodes in bipolar disorder. Cochrane Database Syst Rev. 2003;(1):CD004052.
29. Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR. Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry. 2006;163(7):1199-1201.
30. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord. 2010;12(1):87-94.
31. Castle D, White C, Chamberlain J, et al. Group-based psychosocial intervention for bipolar disorder: randomised controlled trial. Br J Psychiatry. 2010;196(5):383-388.
32. Sullivan AE, Miklowitz DJ. Family functioning among adolescents with bipolar disorder. J Fam Psychol. 2010;24(1):60-67.
33. Morriss RK, Faizal MA, Jones AP, Williamson PR, Bolton C, McCarthy JP. Interventions for helping people recognise early signs of recurrence in bipolar disorder. Cochrane Database Syst Rev. 2007;(1):CD004854.
34. Ostacher MJ, Lebeau RT, Perlis RH, et al. Cigarette smoking is associated with suicidality in bipolar disorder. Bipolar Disord. 2009;11(7):766-771.
35. Cipriani A, Rendell JM, Geddes JR. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev. 2006;(3):CD004362.
36. Rendell JM, Gijsman HJ, Keck P, Goodwin GM, Geddes JR. Olanzapine alone or in combination for acute mania. Cochrane Database Syst Rev. 2003;(3):CD004040.
37. Rendell JM, Gijsman HJ, Bauer MS, Goodwin GM, Geddes GR. Risperidone alone or in combination for acute mania. Cochrane Database Syst Rev. 2006;(1):CD004043.
38. Scherk H, Pajonk FG, Leucht S. Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry. 2007;64(4):442-455.
39. Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar Ior II depression. Am J Psychiatry. 2005;162(7):1351-1360.
40. Van Lieshout RJ, MacQueen GM. Efficacy and acceptability of mood stabilisers in the treatment of acute bipolar depression: systematic review. Br J Psychiatry. 2010;196(4):266-273.
41. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline [published correction appears in Br J Psychiatry. 2006;189:569]. Br J Psychiatry. 2006;189:124-131.
42. Zmitek A. Trazodone-induced mania. Br J Psychiatry. 1987;151:274-275.
43. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001;(3):CD003013.
44. Cipriani A, Rendell JM, Geddes J. Olanzapine in long-term treatment for bipolar disorder. Cochrane Database Syst Rev. 2009;(1):CD004367.
45. Stoll AL, Severus WE, Freeman MP, et al. Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999;56(5):407-412.
46. Milano W, Grillo F, Del Mastro A, et al. Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study. Adv Ther. 2007;24(1):123-134.
47. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry. 2010;167(6):686-693.
48. Lamictal (lamotrigine) [package insert]. Durham, N.C.: GlaxoSmithKline; 2010. http://us.gsk.com/products/assets/us_lamictal.pdf. Accessed September 16, 2010.
49. Zyprexa (olanzepine) [package insert]. Indianapolis, Ind.: Eli Lilly; 2011. http://www.zyprexa.com/Pages/index.aspx. Accessed September 16, 2010.
50. Ativan (lorazepam) [package insert]. Kirkland, Quebec, Canada: Pfizer; 2010. http://www.pfizer.ca/en/our_products/products/monograph/279. Accessed September 16, 2010.
51. Tegretol (carbamazepine) [package insert]. East Hanover, N.J.: Novartis; 2011. http://www.pharma.us.novartis.com/product/pi/pdf/tegretol.pdf. Accessed September 14, 2011.
52. Van Amelsvoort T, Bakshi R, Devaux CB, Schwabe S. Hyponatremia associated with carbamazepine and oxcarbazepine therapy: a review. Epilepsia. 1994;35(1):181-188.
53. Depakote (divalproex sodium) [package insert]. Chicago, Ill.: Abbott Laboratories; 2009. http://www.depakoteer.com/prescribing-information.cfm. Accessed September 14, 2011.
54. Kirov G, Tredget J, John R, Owen MJ, Lazarus JH. A cross-sectional and a prospective study of thyroid disorders in lithium-treated patients. J Affect Disord. 2005;87(2-3):313-317.
55. Justo LP, Soares BG, Calil HM. Family interventions for bipolar disorder. Cochrane Database Syst Rev. 2007;(4):CD005167.
56. Miklowitz DJ. Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry. 2008;165(11):1408-1419.